Trials / Completed
CompletedNCT04839627
Impact of Serum Progesterone Levels on the Day of Fresh and Frozen Embryo Transfer on the Ongoing Pregnancy Rates.
Impact of Serum Progesterone Levels on the Day of Fresh and Frozen Embryo Transfer on the Ongoing Pregnancy Rates
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Hospital St. Joseph, Marseille, France · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Serum progesterone levels prepare the endometrium for implantation and play an important role during embryo transfer (ET). In clinical practice, luteal phase support progesterone supplementation is systematically offered to all women undergoing medically assisted procreation (AMP), independently of ET conditions (fresh and frozen). The investigators propose to perform a prospective cross-sectional single-center cohort study to measure progesterone levels on the day of the ET on all AMP cycles and to compare these levels between active pregnancies and ET unsuccessful cycles. They will determine progesterone threshold levels corresponding to successful attempts in all ET strategies (fresh and frozen) as well as clinical and biological risk factors leading to luteal phase deficiency during ET. They could therefore individualize progesterone supplementation according to patient's needs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | serum progesterone measurement | progesterone levels measurement on the day of the embryo transfer on all AMP cycles |
Timeline
- Start date
- 2021-06-16
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2021-04-09
- Last updated
- 2023-08-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04839627. Inclusion in this directory is not an endorsement.